Rifagut

📦 Elke bestelling is gedekt door onze Reshipment Assurance Policy — als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.

Waarom bestellen bij MedsBase

Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen — geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor — nooit “MedsBase” of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.

What Is Rifagut?

Rifagut is an oral antibiotic tablet containing rifaximin (400 mg or 550 mg), manufactured by Sun Pharma. Supplied in packs of 10, 30 or 60 tablets. Rifaximin is a semi-synthetic rifamycin derived from rifampicin, modified to be non-absorbable from the gut — < 0.4% of an oral dose enters the systemic circulation. This gives it a unique profile: high antibacterial activity in the gut lumen, near-zero systemic exposure, minimal drug interactions, and a low risk of resistance selection outside the gut.

Originator brand: Xifaxan (Salix / Bausch Health, US) and Normix (Alfa Wassermann, EU). Rifaximin has been in clinical use since the 1980s and is approved by the FDA for traveller’s diarrhoea (2004), hepatic encephalopathy (2010), and IBS-D (2015).

What Is Rifagut Used For?

• Traveller’s diarrhoea (non-invasive E. coli strains) — adults and adolescents aged 12+
• Reduction in recurrence of overt hepatic encephalopathy in patients with advanced liver disease — usually combined with lactulose
• Irritable bowel syndrome with diarrhoea (IBS-D) in non-constipated adults — provides weeks to months of symptom relief after a 14-day course; FDA-approved
• Small intestinal bacterial overgrowth (SIBO) — off-label but extensively used; often combined with neomycin for methane-predominant SIBO
• Prophylaxis of spontaneous bacterial peritonitis in cirrhosis (off-label)
• Diverticulitis and some cases of pouchitis after colectomy (off-label)

Rifaximin is niet effective for invasive bacterial infections (Shigella, Salmonella, Campylobacter) causing fever and bloody diarrhoea — systemic antibiotics are needed. It is also not indicated for C. difficile colitis.

How Does Rifagut Work?

Rifaximin inhibits bacterial DNA-dependent RNA polymerase by binding to the β-subunit, preventing transcription — the same mechanism as its parent compound rifampicin. It has broad-spectrum activity against Gram-positive and Gram-negative aerobes and anaerobes.

The key difference from rifampicin is pharmacokinetic:

• < 0.4% oral bioavailability — almost all of the dose stays in the gut lumen
• Very high intraluminal concentrations — far above the MIC for most relevant pathogens
• No meaningful systemic absorption — no hepatic first-pass effect, no peak plasma levels, no systemic side-effect burden
• Minimal drug interactions — unlike rifampicin (a potent CYP inducer), rifaximin does not meaningfully induce or inhibit CYP enzymes
• Low resistance pressure outside the gut — systemic pathogens are not exposed

In IBS-D and SIBO specifically, rifaximin’s benefit is thought to come from reshaping the gut microbiome — reducing bacterial fermentation, gas production, and bile-acid deconjugation that drive symptoms. Effect on symptoms often persists for weeks to months after the 14-day course ends, suggesting a shift toward a more stable microbial community rather than simple pathogen eradication.

Dosering en toediening

Traveller’s diarrhoea (adults and children 12+): 200 mg three times daily for 3 days.

Prevention of recurrent hepatic encephalopathy: 550 mg twice daily (long-term).

IBS with diarrhoea (IBS-D): 550 mg three times daily for 14 days. Relief typically lasts weeks to months. Up to 2 repeat courses allowed for returning symptoms.

SIBO (off-label): 550 mg three times daily for 14 days; some protocols add neomycin 500 mg twice daily for methane-predominant SIBO.

• Take with or without food. Food slightly delays absorption but does not affect clinical effect (because almost nothing is absorbed anyway).
• Complete the full course even if symptoms improve.
• Miss a dose — take as soon as you remember unless close to the next; do not double up.
• For traveller’s diarrhoea, do not use if you have fever or bloody stools (these suggest invasive infection requiring systemic antibiotics).
• Re-evaluate if symptoms do not improve within 24–48 hours for traveller’s diarrhoea, or 2 weeks for IBS-D.

Bijwerkingen

Rifaximin is remarkably well tolerated because it barely enters the bloodstream.

Vaak voorkomend:

• Hoofdpijn
• Mild nausea, abdominal discomfort
• Flatulence, bloating
• Dizziness, fatigue

Minder vaak voorkomend:

• Rash, pruritus
• Peripheral oedema
• Muscle spasm
• Zeldzaam: Clostridioides difficile-associated colitis — any antibiotic including rifaximin can disrupt gut flora enough to allow C. difficile overgrowth, although the risk is lower than with systemic antibiotics
• Very rare: hypersensitivity reactions (including rare cases of Stevens-Johnson syndrome)

Geneesmiddelinteracties

Rifaximin’s near-zero systemic absorption means it has few clinically significant drug interactions. Notable points:

• Orale anticonceptiva — in theory broad-spectrum antibiotics can reduce efficacy by disrupting enterohepatic recycling of contraceptive oestrogen. Clinical significance with rifaximin specifically is small but back-up contraception during and 7 days after a course is conservative.
• Warfarine — gut-flora disruption can alter vitamin K metabolism; monitor INR.
• Cyclosporine — may increase rifaximin systemic levels (P-gp interaction). Usually not clinically important.
• No meaningful CYP-enzyme interactions — the major advantage over rifampicin.

Who Should Not Take Rifagut?

• Known hypersensitivity to rifaximin, rifamycins (rifampicin, rifabutin), or any excipient
• Intestinal obstruction
• Severe hepatic impairment (Child-Pugh C) — rare but systemic absorption can increase
• Bloody diarrhoea or diarrhoea with fever — these suggest invasive infection needing systemic antibiotics, not rifaximin
• Pregnancy and breastfeeding — limited data; avoid unless benefit outweighs risk (low systemic absorption is theoretically reassuring)
• Children below the label age for the indication

Opslag

Store Rifagut below 30°C in a dry place, in the original blister. Keep out of reach of children.

Veelgestelde vragen

Is Rifagut the same as Xifaxan or Normix?

Yes — Rifagut contains the same active ingredient (rifaximin) at the same strengths as Xifaxan (US; Salix) and Normix (EU; Alfa Wassermann). Bioequivalence is required by regulatory authorities.

How does Rifagut work for IBS-D if IBS is not an infection?

IBS-D is not caused by a pathogen, but a subset of patients have disturbed gut microbiota and bacterial overgrowth contributing to symptoms. Rifaximin works by modulating the gut flora — reducing fermenting bacteria, bile-acid deconjugation, and mucosal inflammation. The effect often persists weeks to months after a 14-day course, which is why the protocol allows 1–2 repeat courses when symptoms return.

How long does relief last after a 14-day IBS-D course?

In the TARGET 3 trial (FDA pivotal study), the median duration of response after a 550 mg TID × 14-day course was 10–18 weeks. Many patients experience longer relief; some respond to repeat courses when symptoms return.

Is Rifagut safe — I worry about taking antibiotics?

Rifaximin is unusually safe for an antibiotic because < 0.4% is absorbed into the bloodstream. Systemic side effects are minimal; drug interactions are minimal; resistance pressure on non-gut bacteria is minimal. The main concern with any antibiotic is C. difficile colitis, which is rare with rifaximin compared with systemic antibiotics. Still, rifaximin should be used for the right indication and duration, not as a general remedy.

Can I use Rifagut for traveller’s diarrhoea — when should I not?

Rifaximin works for non-invasive E. coli traveller’s diarrhoea (the commonest type). Do not use rifaximin if you have fever or bloody stools — these suggest invasive Shigella, Salmonella, of Campylobacter, which need systemic antibiotics such as ciprofloxacin or azithromycin.

Can I take Rifagut with probiotics?

Yes — many clinicians combine a rifaximin course with probiotics (especially in SIBO protocols). Separate by 2–3 hours if possible. Some evidence suggests combining rifaximin with Saccharomyces boulardii or a multi-strain probiotic may improve results.

Where can I buy Rifagut online?

You can order Rifagut (400 mg or 550 mg) from MedsBase in packs of 10, 30 or 60 tablets. We ship worldwide with discreet packaging and genuine Sun Pharma manufacturer stock.

Related IBS & IBD Medications

• Colospa — Mebeverine (IBS antispasmodic)
• Mesacol — Mesalamine (ulcerative colitis)
• Asacol — Mesalamine (UC)
• Mesacol OD — Mesalamine once-daily MMX
• Sazo — Sulfasalazine
• Salazar — Sulfasalazine
• Browse all IBS & IBD Medications

Waarom bestellen bij MedsBase

Rifagut is supplied from a WHO-GMP gecertificeerde fabrikant. Every order ships discreetly worldwide and is covered by our Reshipment Assurance Policy — if it does not arrive within 20 business days, we reship at no cost. Rifaximin is a gut-selective non-absorbed antibiotic with negligible systemic absorption (< 0.4 percent) and is endorsed for traveller’s diarrhoea, hepatic encephalopathy, and IBS-D.

More options in Diarrhoea Treatment

Gerangschikt op recente bestelvolumes van MedsBase — wat andere klanten in deze categorie kiezen.

Nizonide

US$90.00 – US$835.00Fourchette de prix : US$90.00 à US$835.00

Imodium

US$42.00 – US$163.00Fourchette de prix : US$42.00 à US$163.00